ARCHIVES

Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS

This article is from The Cancer Letter archive.

Vol. 17 No. 37 | September 27, 1991

Download PDF Visit The Full Archive

Related Articles

European Compound enhances IL-2 In BRMP Mouse Study; BRMP Mouse Study; Rosemberg Describes System Improvements, Updates Results

June 5, 1987

In Brief: FASEB Letter urges Support Of NIH, NSF; Kansas Recruits Experts From Washington State

July 30, 1993

NCI-Funded Modelers Accurately Predicted Outcome Of Lung Cancer Screening Trial

November 26, 2010

NCI Advisory Group, Other Cancer Meetings

January 30, 1976

Clinical Nutrition Academic Award Concept Approved

October 4, 1985

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

October 28, 2005